Abstract
Background: Trichotillomania (TTM), also known as hair pulling disorder, is a chronic disorder that often leads to considerable emotional distress and functional impairment in affected individuals. Despite the strong underlying psychiatric component of TTM, the majority of individuals suffering from TTM initially may present to dermatologists because of their hair loss. This necessitates awareness and early recognition of TTM as well as familiarity with the unique considerations for its management. Summary: This study reviews the limited literature regarding quality of life in TTM, the methodologies employed to assess quality of life, and further explores the necessity of an interdisciplinary clinical approach to treatment. Several studies included in this review demonstrated the significant degree to which TTM reduces quality of life. Multiple treatment modalities for TTM have been successfully used in the literature that incorporate a comprehensive approach to management and ultimately address the underlying psychiatric component of TTM. Key Messages: TTM significantly reduces the quality of life in affected individuals. Successful management of TTM requires an interdisciplinary approach that bridges dermatology and psychiatry. Screening tools that assess the impact of TTM on quality of life are clinically useful and essential for early diagnosis and optimal management.
Journal Section:
Review Article
References
1.
American Psychiatric Association
. Diagnostic and statistical manual of mental disorders
. 5th ed.Arlington, VA
: American Psychiatric Association
; 2013
.2.
Alessandrini
A
, Bruni
F
, Piraccini
BM
, Starace
M
. Common causes of hair loss - clinical manifestations, trichoscopy and therapy
. J Eur Acad Dermatol Venereol
. 2021
;35
(3
):629
–40
. 3.
Grant
JE
, Chamberlain
SR
. Trichotillomania
. Am J Psychiatry
. 2016
;173
(9
):868
–74
. 4.
Thomson
HA
, Farhat
LC
, Olfson
E
, Levine
JLS
, Bloch
MH
. Prevalence and gender distribution of trichotillomania: a systematic review and meta-analysis
. J Psychiatr Res
. 2022
;153
:73
–81
. 5.
Snorrason
I
, Ricketts
EJ
, Stein
AT
, Thamrin
H
, Lee
SJ
, Goldberg
H
, et al. Sex differences in age at onset and presentation of trichotillomania and trichobezoar: a 120-year systematic review of cases
. Child Psychiatry Hum Dev
. 2022
;53
(1
):165
–71
. 6.
Melo
DF
, Lima
CDS
, Piraccini
BM
, Tosti
A
. Trichotillomania: what do we know so far
. Skin Appendage Disord
. 2022
;8
(1
):1
–7
. 7.
Pereyra
AD
, Saadabadi
A
. Trichotillomania
. Treasure island (FL)
: StatPearls Publishing
; 2023
.8.
Grant
JE
, Chamberlain
SR
. Natural recovery in trichotillomania
. Aust N Z J Psychiatry
. 2022
;56
(10
):1357
–62
. 9.
Lochner
C
, Keuthen
NJ
, Curley
EE
, Tung
ES
, Redden
SA
, Ricketts
EJ
, et al. Comorbidity in trichotillomania (hair-pulling disorder): a cluster analytical approach
. Brain Behav
. 2019
;9
(12
):e01456
. 10.
Mubki
T
, Rudnicka
L
, Olszewska
M
, Shapiro
J
. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination
. J Am Acad Dermatol
. 2014
;71
(3
):415.e1
–15
. 11.
Waśkiel
A
, Rakowska
A
, Sikora
M
, Olszewska
M
, Rudnicka
L
. Trichoscopy of alopecia areata: an update
. J Dermatol
. 2018
;45
(6
):692
–700
. 12.
Weidt
S
, Klaghofer
R
, Kuenburg
A
, Bruehl
AB
, Delsignore
A
, Moritz
S
, et al. Internet-based self-help for trichotillomania: a randomized controlled study comparing decoupling and progressive muscle relaxation
. Psychother Psychosom
. 2015
;84
(6
):359
–67
. 13.
Rogers
K
, Banis
M
, Falkenstein
MJ
, Malloy
EJ
, McDonough
L
, Nelson
SO
, et al. Stepped care in the treatment of trichotillomania
. J Consult Clin Psychol
. 2014
;82
(2
):361
–7
. 14.
Diener
E
, Emmons
RA
, Larsen
RJ
, Griffin
S
. The satisfaction with life scale
. J Pers Assess
. 1985
;49
(1
):71
–5
. 15.
Heskeyahu
T
. Quality of life in clinical and sub-clinical trichotillomania in females
. Marywood University
; 2008
.16.
Sheehan
KH
, Sheehan
DV
. Assessing treatment effects in clinical trials with the discan metric of the sheehan disability scale
. Int Clin Psychopharmacol
. 2008
;23
(2
):70
–83
. 17.
Diefenbach
GJ
, Tolin
DF
, Hannan
S
, Crocetto
J
, Worhunsky
P
. Trichotillomania: impact on psychosocial functioning and quality of life
. Behav Res Ther
. 2005
;43
(7
):869
–84
. 18.
Grant
JE
, Odlaug
BL
, Kim
SW
. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study
. Arch Gen Psychiatry
. 2009
;66
(7
):756
–63
. 19.
Grant
JE
, Odlaug
BL
, Chamberlain
SR
, Kim
SW
. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study
. Psychopharmacology
. 2011
;218
(3
):493
–502
. 20.
Leppink
EW
, Redden
SA
, Grant
JE
. A double-blind, placebo-controlled study of inositol in trichotillomania
. Int Clin Psychopharmacol
. 2017
;32
(2
):107
–14
. 21.
Phillips
TG
, Slomiany
WP
, Allison
R
. Hair loss: common causes and treatment
. Am Fam Physician
. 2017
;96
(6
):371
–8
.22.
Grant
JE
. Trichotillomania (hair pulling disorder)
. Indian J Psychiatry
. 2019
;61
(7
):136
. 23.
Tolin
DF
, Franklin
ME
, Diefenbach
GJ
, Anderson
E
, Meunier
SA
. Pediatric trichotillomania: descriptive psychopathology and an open trial of cognitive behavioral therapy
. Cogn Behav Ther
. 2007
;36
(3
):129
–44
. 24.
Franklin
ME
, Edson
AL
, Ledley
DA
, Cahill
SP
. Behavior therapy for pediatric trichotillomania: a randomized controlled trial
. J Am Acad Child Adolesc Psychiatry
. 2011
;50
(8
):763
–71
. 25.
Twohig
MP
, Petersen
JM
, Fruge
J
, Ong
CW
, Barney
JL
, Krafft
J
, et al. A pilot randomized controlled trial of online-delivered ACT-enhanced behavior therapy for trichotillomania in adolescents
. Cognit Behav Pract
. 2021
;28
(4
):653
–68
. 26.
Rahman
O
, McGuire
J
, Storch
EA
, Lewin
AB
. Preliminary randomized controlled trial of habit reversal training for treatment of hair pulling in youth
. J Child Adolesc Psychopharmacol
. 2017
;27
(2
):132
–9
. 27.
Bloch
MH
, Panza
KE
, Grant
JE
, Pittenger
C
, Leckman
JF
. N-acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial
. J Am Acad Child Adolesc Psychiatry
. 2013
;52
(3
):231
–40
. 28.
Popova
L
, Mancuso
J
. Dramatic improvement of trichotillomania with 6 months of treatment with N-acetylcysteine
. Glob Pediatr Health
. 2022
;9
:2333794X221086576
. 29.
Hautmann
G
, Hercogova
J
, Lotti
T
. Trichotillomania
. J Am Acad Dermatol
. 2002
;46
(6
):807
–26
. 30.
Zhou
C
, Li
X
, Wang
C
, Zhang
J
. Alopecia areata: an update on etiopathogenesis, diagnosis, and management
. Clin Rev Allergy Immunol
. 2021
;61
(3
):403
–23
. 31.
Christensen
RE
, Schambach
M
, Jafferany
M
. Microneedling as an adjunctive treatment for trichotillomania
. Dermatol Ther
. 2022
;35
(11
):e15824
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
